Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Inguinal Hernia: Lap vs Open.

Hernia : the journal of hernias and abdominal wall surgery

Vassiliadis A, Zanoni A, Di Leo A, Zanella S, Lauro E, Moscatelli P, Ricci F, Huang H, Wada N, Furukawa T, Kitagawa Y, Hirukawa H, Takesue Y, Saito K, Sato H, Tada T, Choua O, Fu XJ, Yao QY, Yang S, Wang MG, Zhu YL, Cao JX, Shen YM, Togbe JO, Gbessi DG, Dossou FM, Iawani I, Cijan V, Gencic M, Scepanovic M, Bojovic P, Brankovic M, Agresta F, Verza LA, Prando D, Roveran MA, Azabdaftari A, Rubinato L, Vacca U, Lubrano T, Vidotto C, Falcone A, Grasso L, Ghiglione F, Morino M, Nácul M, Cavazzola L, Loureiro M, Bonin E, Ferreira P, Misra MC, Bansal VK, Subodh K, Krisha A, Bansal D, Ray S, Rajeshwari S, Wang P, Jia Z, Zhang FJ, Yan JJ, Zhu YH, Jiang K, Altinli E, Eroglu E, Sertel HI, Hizli F, Jacob B, Bresnaham E, Reiner M, Bates A.
PMID: 26518862
Hernia. 2015 Apr;19:S57-62. doi: 10.1007/BF03355327.

No abstract available.

Cite
Vassiliadis A, Zanoni A, Di Leo A, et al. Inguinal Hernia: Lap vs Open. Hernia. 2015;19:S57-62doi: 10.1007/BF03355327.
Vassiliadis, A., Zanoni, A., Di Leo, A., Zanella, S., Lauro, E., Moscatelli, P., Ricci, F., Huang, H., Wada, N., Furukawa, T., Kitagawa, Y., Hirukawa, H., Takesue, Y., Saito, K., Sato, H., Tada, T., Choua, O., Fu, X. J., Yao, Q. Y., Yang, S., Wang, M. G., Zhu, Y. L., Cao, J. X., Shen, Y. M., Togbe, J. O., Gbessi, D. G., Dossou, F. M., Iawani, I., Cijan, V., Gencic, M., Scepanovic, M., Bojovic, P., Brankovic, M., Agresta, F., Verza, L. A., Prando, D., Roveran, M. A., Azabdaftari, A., Rubinato, L., Vacca, U., Lubrano, T., Vidotto, C., Falcone, A., Grasso, L., Ghiglione, F., Morino, M., Nácul, M., Cavazzola, L., Loureiro, M., Bonin, E., Ferreira, P., Misra, M. C., Bansal, V. K., Subodh, K., Krisha, A., Bansal, D., Ray, S., Rajeshwari, S., Wang, P., Jia, Z., Zhang, F. J., Yan, J. J., Zhu, Y. H., Jiang, K., Altinli, E., Eroglu, E., Sertel, H. I., Hizli, F., Jacob, B., Bresnaham, E., Reiner, M., & Bates, A. (2015). Inguinal Hernia: Lap vs Open. Hernia : the journal of hernias and abdominal wall surgery, 19S57-62. https://doi.org/10.1007/BF03355327
Vassiliadis, A, et al. "Inguinal Hernia: Lap vs Open." Hernia : the journal of hernias and abdominal wall surgery vol. 19 (2015): S57-62. doi: https://doi.org/10.1007/BF03355327
Vassiliadis A, Zanoni A, Di Leo A, Zanella S, Lauro E, Moscatelli P, Ricci F, Huang H, Wada N, Furukawa T, Kitagawa Y, Hirukawa H, Takesue Y, Saito K, Sato H, Tada T, Choua O, Fu XJ, Yao QY, Yang S, Wang MG, Zhu YL, Cao JX, Shen YM, Togbe JO, Gbessi DG, Dossou FM, Iawani I, Cijan V, Gencic M, Scepanovic M, Bojovic P, Brankovic M, Agresta F, Verza LA, Prando D, Roveran MA, Azabdaftari A, Rubinato L, Vacca U, Lubrano T, Vidotto C, Falcone A, Grasso L, Ghiglione F, Morino M, Nácul M, Cavazzola L, Loureiro M, Bonin E, Ferreira P, Misra MC, Bansal VK, Subodh K, Krisha A, Bansal D, Ray S, Rajeshwari S, Wang P, Jia Z, Zhang FJ, Yan JJ, Zhu YH, Jiang K, Altinli E, Eroglu E, Sertel HI, Hizli F, Jacob B, Bresnaham E, Reiner M, Bates A. Inguinal Hernia: Lap vs Open. Hernia. 2015 Apr;19:S57-62. doi: 10.1007/BF03355327. PMID: 26518862.
Copy Download .nbib Format: NLM
Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring".

mSphere

Mahic M, Mjaaland S, Bøvelstad HM, Gunnes N, Susser E, Bresnahan M, Øyen AS, Levin B, Che X, Hirtz D, Reichborn-Kjennerud T, Schjølberg S, Roth C, Magnus P, Stoltenberg C, Surén P, Hornig M, Lipkin WI.
PMID: 28435887
mSphere. 2017 Apr 12;2(2). doi: 10.1128/mSphere.00154-17. eCollection 2017.

[This corrects the article DOI: 10.1128/mSphere.00016-17.].

Cite
Mahic M, Mjaaland S, Bøvelstad HM, et al. Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring". mSphere. 2017;2(2)doi: 10.1128/mSphere.00154-17.
Mahic, M., Mjaaland, S., Bøvelstad, H. M., Gunnes, N., Susser, E., Bresnahan, M., Øyen, A. S., Levin, B., Che, X., Hirtz, D., Reichborn-Kjennerud, T., Schjølberg, S., Roth, C., Magnus, P., Stoltenberg, C., Surén, P., Hornig, M., & Lipkin, W. I. (2017). Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring". mSphere, 2(2), . https://doi.org/10.1128/mSphere.00154-17
Mahic, Milada, et al. "Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring"." mSphere vol. 2,2 (2017). doi: https://doi.org/10.1128/mSphere.00154-17
Mahic M, Mjaaland S, Bøvelstad HM, Gunnes N, Susser E, Bresnahan M, Øyen AS, Levin B, Che X, Hirtz D, Reichborn-Kjennerud T, Schjølberg S, Roth C, Magnus P, Stoltenberg C, Surén P, Hornig M, Lipkin WI. Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring". mSphere. 2017 Apr 12;2(2). doi: 10.1128/mSphere.00154-17. eCollection 2017. PMID: 28435887; PMCID: PMC5390096.
Copy Download .nbib Format: NLM
Origins of epidemiology.

Annals of the New York Academy of Sciences

Susser E, Bresnahan M.
PMID: 11797866
Ann N Y Acad Sci. 2001 Dec;954:6-18. doi: 10.1111/j.1749-6632.2001.tb02743.x.

In this paper we trace the history of epidemiology from 1800 to the present time. The history is highly selective because our purpose is to illuminate the evolving relationship of epidemiology with demography. We first describe the common "prehistory"...

Cite
Susser E, Bresnahan M. Origins of epidemiology. Ann N Y Acad Sci. 2001;954:6-18doi: 10.1111/j.1749-6632.2001.tb02743.x.
Susser, E., & Bresnahan, M. (2001). Origins of epidemiology. Annals of the New York Academy of Sciences, 9546-18. https://doi.org/10.1111/j.1749-6632.2001.tb02743.x
Susser, E, and Bresnahan, M. "Origins of epidemiology." Annals of the New York Academy of Sciences vol. 954 (2001): 6-18. doi: https://doi.org/10.1111/j.1749-6632.2001.tb02743.x
Susser E, Bresnahan M. Origins of epidemiology. Ann N Y Acad Sci. 2001 Dec;954:6-18. doi: 10.1111/j.1749-6632.2001.tb02743.x. PMID: 11797866.
Copy Download .nbib Format: NLM
The emerging role of outdoor and indoor air pollution in cardiovascular disease.

North American journal of medical sciences

Uzoigwe JC, Prum T, Bresnahan E, Garelnabi M.
PMID: 24083218
N Am J Med Sci. 2013 Aug;5(8):445-53. doi: 10.4103/1947-2714.117290.

Outdoor and indoor air pollution poses a significant cardiovascular risk, and has been associated with atherosclerosis, the main underlying pathology in many cardiovascular diseases. Although, it is well known that exposure to air pollution causes pulmonary disease, recent studies...

Cite
Uzoigwe JC, Prum T, Bresnahan E, et al. The emerging role of outdoor and indoor air pollution in cardiovascular disease. N Am J Med Sci. 2013;5(8):445-53doi: 10.4103/1947-2714.117290.
Uzoigwe, J. C., Prum, T., Bresnahan, E., & Garelnabi, M. (2013). The emerging role of outdoor and indoor air pollution in cardiovascular disease. North American journal of medical sciences, 5(8), 445-53. https://doi.org/10.4103/1947-2714.117290
Uzoigwe, Jacinta C, et al. "The emerging role of outdoor and indoor air pollution in cardiovascular disease." North American journal of medical sciences vol. 5,8 (2013): 445-53. doi: https://doi.org/10.4103/1947-2714.117290
Uzoigwe JC, Prum T, Bresnahan E, Garelnabi M. The emerging role of outdoor and indoor air pollution in cardiovascular disease. N Am J Med Sci. 2013 Aug;5(8):445-53. doi: 10.4103/1947-2714.117290. PMID: 24083218; PMCID: PMC3784920.
Copy Download .nbib Format: NLM
Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes.

Epileptic disorders : international epilepsy journal with videotape

Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance WC, Goldstein LH, Gandy M, Bresnahan R, Valente K, Donald KA, Reuber M.
PMID: 34730519
Epileptic Disord. 2021 Dec 01;23(6):803-811. doi: 10.1684/epd.2021.1357.

Clinical interest in using psychological interventions for people with epilepsy (PWE) aiming at decreasing mental health difficulties, improving health-related quality of life (HRQOL) and seizure-related outcomes, continues to grow. This article summarizes the 2020 update of the 2017 Cochrane...

Cite
Michaelis R, Tang V, Nevitt SJ, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic Disord. 2021;23(6):803-811doi: 10.1684/epd.2021.1357.
Michaelis, R., Tang, V., Nevitt, S. J., Wagner, J. L., Modi, A. C., LaFrance, W. C., Goldstein, L. H., Gandy, M., Bresnahan, R., Valente, K., Donald, K. A., & Reuber, M. (2021). Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic disorders : international epilepsy journal with videotape, 23(6), 803-811. https://doi.org/10.1684/epd.2021.1357
Michaelis, Rosa, et al. "Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes." Epileptic disorders : international epilepsy journal with videotape vol. 23,6 (2021): 803-811. doi: https://doi.org/10.1684/epd.2021.1357
Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance WC, Goldstein LH, Gandy M, Bresnahan R, Valente K, Donald KA, Reuber M. Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic Disord. 2021 Dec 01;23(6):803-811. doi: 10.1684/epd.2021.1357. PMID: 34730519.
Copy Download .nbib Format: NLM
Topiramate add-on therapy for drug-resistant focal epilepsy.

The Cochrane database of systematic reviews

Bresnahan R, Hounsome J, Jette N, Hutton JL, Marson AG.
PMID: 31642054
Cochrane Database Syst Rev. 2019 Oct 23;10:CD001417. doi: 10.1002/14651858.CD001417.pub4. Epub 2019 Oct 23.

BACKGROUND: The majority of people with epilepsy have a good prognosis and their seizures are controlled by a single antiepileptic drug. However, up to 20% of patients from population-based studies, and up to 30% from clinical series (not population-based),...

Cite
Bresnahan R, Hounsome J, Jette N, et al. Topiramate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2019;10:CD001417doi: 10.1002/14651858.CD001417.pub4.
Bresnahan, R., Hounsome, J., Jette, N., Hutton, J. L., & Marson, A. G. (2019). Topiramate add-on therapy for drug-resistant focal epilepsy. The Cochrane database of systematic reviews, 10CD001417. https://doi.org/10.1002/14651858.CD001417.pub4
Bresnahan, Rebecca, et al. "Topiramate add-on therapy for drug-resistant focal epilepsy." The Cochrane database of systematic reviews vol. 10 (2019): CD001417. doi: https://doi.org/10.1002/14651858.CD001417.pub4
Bresnahan R, Hounsome J, Jette N, Hutton JL, Marson AG. Topiramate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2019 Oct 23;10:CD001417. doi: 10.1002/14651858.CD001417.pub4. Epub 2019 Oct 23. PMID: 31642054; PMCID: PMC6806021.
Copy Download .nbib Format: NLM
Reply to Magaret and Wald, "Autism Link to Herpes Simplex Virus 2 Antibody in Pregnancy Likely To Be Spurious".

mSphere

Mahic M, Mjaaland S, Susser E, Bresnahan M, Che X, Levin B, Hornig M, Lipkin WI.
PMID: 28409568
mSphere. 2017 Mar 29;2(2). doi: 10.1128/mSphere.00113-17. eCollection 2017.

No abstract available.

Cite
Mahic M, Mjaaland S, Susser E, et al. Reply to Magaret and Wald, "Autism Link to Herpes Simplex Virus 2 Antibody in Pregnancy Likely To Be Spurious". mSphere. 2017;2(2)doi: 10.1128/mSphere.00113-17.
Mahic, M., Mjaaland, S., Susser, E., Bresnahan, M., Che, X., Levin, B., Hornig, M., & Lipkin, W. I. (2017). Reply to Magaret and Wald, "Autism Link to Herpes Simplex Virus 2 Antibody in Pregnancy Likely To Be Spurious". mSphere, 2(2), . https://doi.org/10.1128/mSphere.00113-17
Mahic, Milada, et al. "Reply to Magaret and Wald, "Autism Link to Herpes Simplex Virus 2 Antibody in Pregnancy Likely To Be Spurious"." mSphere vol. 2,2 (2017). doi: https://doi.org/10.1128/mSphere.00113-17
Mahic M, Mjaaland S, Susser E, Bresnahan M, Che X, Levin B, Hornig M, Lipkin WI. Reply to Magaret and Wald, "Autism Link to Herpes Simplex Virus 2 Antibody in Pregnancy Likely To Be Spurious". mSphere. 2017 Mar 29;2(2). doi: 10.1128/mSphere.00113-17. eCollection 2017. PMID: 28409568; PMCID: PMC5371695.
Copy Download .nbib Format: NLM
Carisbamate add-on therapy for drug-resistant focal epilepsy.

The Cochrane database of systematic reviews

Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ.
PMID: 34870321
Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2.

BACKGROUND: Epilepsy is one of the most common neurological disorders. Many people with epilepsy are drug-resistant and require add-on therapy, meaning that they concomitantly take multiple antiepileptic drugs. Carisbamate is a drug which is taken orally and inhibits voltage-gated...

Cite
Lu C, Zheng J, Cao Y, et al. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021;12:CD012121doi: 10.1002/14651858.CD012121.pub2.
Lu, C., Zheng, J., Cao, Y., Bresnahan, R., & Martin-McGill, K. J. (2021). Carisbamate add-on therapy for drug-resistant focal epilepsy. The Cochrane database of systematic reviews, 12CD012121. https://doi.org/10.1002/14651858.CD012121.pub2
Lu, Chuansen, et al. "Carisbamate add-on therapy for drug-resistant focal epilepsy." The Cochrane database of systematic reviews vol. 12 (2021): CD012121. doi: https://doi.org/10.1002/14651858.CD012121.pub2
Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2. PMID: 34870321; PMCID: PMC8647098.
Copy Download .nbib Format: NLM
Carisbamate add-on therapy for drug-resistant focal epilepsy.

The Cochrane database of systematic reviews

Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ.
PMID: 34870321
Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2.

BACKGROUND: Epilepsy is one of the most common neurological disorders. Many people with epilepsy are drug-resistant and require add-on therapy, meaning that they concomitantly take multiple antiepileptic drugs. Carisbamate is a drug which is taken orally and inhibits voltage-gated...

Cite
Lu C, Zheng J, Cao Y, et al. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021;12:CD012121doi: 10.1002/14651858.CD012121.pub2.
Lu, C., Zheng, J., Cao, Y., Bresnahan, R., & Martin-McGill, K. J. (2021). Carisbamate add-on therapy for drug-resistant focal epilepsy. The Cochrane database of systematic reviews, 12CD012121. https://doi.org/10.1002/14651858.CD012121.pub2
Lu, Chuansen, et al. "Carisbamate add-on therapy for drug-resistant focal epilepsy." The Cochrane database of systematic reviews vol. 12 (2021): CD012121. doi: https://doi.org/10.1002/14651858.CD012121.pub2
Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2. PMID: 34870321.
Copy Download .nbib Format: NLM
Carisbamate add-on therapy for drug-resistant focal epilepsy.

The Cochrane database of systematic reviews

Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ.
PMID: 34870321
Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2.

BACKGROUND: Epilepsy is one of the most common neurological disorders. Many people with epilepsy are drug-resistant and require add-on therapy, meaning that they concomitantly take multiple antiepileptic drugs. Carisbamate is a drug which is taken orally and inhibits voltage-gated...

Cite
Lu C, Zheng J, Cao Y, et al. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021;12:CD012121doi: 10.1002/14651858.CD012121.pub2.
Lu, C., Zheng, J., Cao, Y., Bresnahan, R., & Martin-McGill, K. J. (2021). Carisbamate add-on therapy for drug-resistant focal epilepsy. The Cochrane database of systematic reviews, 12CD012121. https://doi.org/10.1002/14651858.CD012121.pub2
Lu, Chuansen, et al. "Carisbamate add-on therapy for drug-resistant focal epilepsy." The Cochrane database of systematic reviews vol. 12 (2021): CD012121. doi: https://doi.org/10.1002/14651858.CD012121.pub2
Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ. Carisbamate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2021 Dec 06;12:CD012121. doi: 10.1002/14651858.CD012121.pub2. PMID: 34870321; PMCID: PMC8647098.
Copy Download .nbib Format: NLM
Development and Preliminary Feasibility of iByte4Health: A Mobile Health (mHealth) Pediatric Obesity Prevention Intervention to Engage Parents with Low-Income of Children 2-9 Years.

Nutrients

Tripicchio GL, Kay M, Herring S, Cos T, Bresnahan C, Gartner D, Sosinsky LS, Bass SB.
PMID: 34959792
Nutrients. 2021 Nov 25;13(12). doi: 10.3390/nu13124240.

This research describes the development and preliminary feasibility of iByte4Health, a mobile health (mHealth) obesity prevention intervention designed for parents with a low-income of children 2-9 years of age. Study 1 (

Cite
Tripicchio GL, Kay M, Herring S, et al. Development and Preliminary Feasibility of iByte4Health: A Mobile Health (mHealth) Pediatric Obesity Prevention Intervention to Engage Parents with Low-Income of Children 2-9 Years. Nutrients. 2021;13(12)doi: 10.3390/nu13124240.
Tripicchio, G. L., Kay, M., Herring, S., Cos, T., Bresnahan, C., Gartner, D., Sosinsky, L. S., & Bass, S. B. (2021). Development and Preliminary Feasibility of iByte4Health: A Mobile Health (mHealth) Pediatric Obesity Prevention Intervention to Engage Parents with Low-Income of Children 2-9 Years. Nutrients, 13(12), . https://doi.org/10.3390/nu13124240
Tripicchio, Gina L, et al. "Development and Preliminary Feasibility of iByte4Health: A Mobile Health (mHealth) Pediatric Obesity Prevention Intervention to Engage Parents with Low-Income of Children 2-9 Years." Nutrients vol. 13,12 (2021). doi: https://doi.org/10.3390/nu13124240
Tripicchio GL, Kay M, Herring S, Cos T, Bresnahan C, Gartner D, Sosinsky LS, Bass SB. Development and Preliminary Feasibility of iByte4Health: A Mobile Health (mHealth) Pediatric Obesity Prevention Intervention to Engage Parents with Low-Income of Children 2-9 Years. Nutrients. 2021 Nov 25;13(12). doi: 10.3390/nu13124240. PMID: 34959792.
Copy Download .nbib Format: NLM
Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes.

Epileptic disorders : international epilepsy journal with videotape

Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance WC, Goldstein LH, Gandy M, Bresnahan R, Valente K, Donald KA, Reuber M.
PMID: 34730519
Epileptic Disord. 2021 Nov 02; doi: 10.1684/epd.2021.1357. Epub 2021 Nov 02.

Clinical interest in using psychological interventions for people with epilepsy (PWE) aiming at decreasing mental health difficulties, improving health-related quality of life (HRQOL) and seizure-related outcomes, continues to grow. This article summarizes the 2020 update of the 2017 Cochrane...

Cite
Michaelis R, Tang V, Nevitt SJ, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic Disord. 2021;doi: 10.1684/epd.2021.1357.
Michaelis, R., Tang, V., Nevitt, S. J., Wagner, J. L., Modi, A. C., LaFrance, W. C., Goldstein, L. H., Gandy, M., Bresnahan, R., Valente, K., Donald, K. A., & Reuber, M. (2021). Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic disorders : international epilepsy journal with videotape, . https://doi.org/10.1684/epd.2021.1357
Michaelis, Rosa, et al. "Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes." Epileptic disorders : international epilepsy journal with videotape vol. (2021). doi: https://doi.org/10.1684/epd.2021.1357
Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance WC, Goldstein LH, Gandy M, Bresnahan R, Valente K, Donald KA, Reuber M. Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic Disord. 2021 Nov 02; doi: 10.1684/epd.2021.1357. Epub 2021 Nov 02. PMID: 34730519.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries